IGF2BP3 and breast carcinoma: In triple-negative breast cancer, IGF2BP3 and IGF2BP2 synergistically recruited CNOT1 complex, reduced the stability of progesterone receptor and ultimately promoted the migration and metastasis of breast cancer [14].